These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14200614)

  • 41. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Observation of the protective effect of live measles vaccines in the first year after vaccination.
    Sejda J; Helcl J; Strauss J
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(3):288-95. PubMed ID: 4161911
    [No Abstract]   [Full Text] [Related]  

  • 43. Development of extremely attenuated live measles virus vaccine (CAM-EX).
    Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
    Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
    [No Abstract]   [Full Text] [Related]  

  • 44. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 45. COMPARISON OF THE HEMAGGLUTINATION INHIBITION TEST FOR MEASLES WITH SEROLOGICAL TESTS AND ITS APPLICATION TO A FIELD TRIAL.
    KUNITA N; KITAWAKI T; FUNAHASHI S; TOYOSHIMA K
    Biken J; 1963 Jul; 6():45-56. PubMed ID: 14147705
    [No Abstract]   [Full Text] [Related]  

  • 46. [CHANGES IN TUBERCULIN ALLERGY IN SUBJECTS HAVING BEEN VACCINATED AGAINST MEASLES BY ATTENUATED VACCINE].
    YOSHIDA Y; YAMAMOTO H; KANEKO I; AKAMATSU H; KUMODE S
    Acta Paediatr Jpn; 1964 Dec; 26():19-25. PubMed ID: 14319123
    [No Abstract]   [Full Text] [Related]  

  • 47. [Results of the inoculation test of measles vaccine. 1. The result of measles-attenuated live virus vaccine].
    Santo K
    Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):332-43. PubMed ID: 4168846
    [No Abstract]   [Full Text] [Related]  

  • 48. RESPONSE OF ADULTS IN ICELAND TO LIVE ATTENUATED MEASLES VACCINE.
    GUDNADOTTIR M; BLACK FL
    Bull World Health Organ; 1964; 30(6):753-62. PubMed ID: 14215182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RESPONSE OF VOLTA CHILDREN TO JET INOCULATION OF COMBINED LIVE MEASLES, SMALLPOX AND YELLOW FEVER VACCINES.
    MEYER HM; HOSTETLER DD; BERNHEIN BC; ROGERS NG; LAMBIN P; CHASSARY A; LABUSQUIERE R; SMADEL JE
    Bull World Health Organ; 1964; 30(6):783-94. PubMed ID: 14215185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IMMUNIZATION WITH A FURTHER ATTENUATED LIVE MEASLES VACCINE.
    SCHWARZ AJ; ANDERSON JT
    Arch Gesamte Virusforsch; 1965; 16():273-8. PubMed ID: 14322877
    [No Abstract]   [Full Text] [Related]  

  • 51. A comparative study of two live measles vaccines in Iran.
    Mirchamsy H; Shafyi A; Bassali Y; Bahrami S; Nazari F
    J Hyg (Lond); 1970 Mar; 68(1):101-10. PubMed ID: 5266577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined measles-rubella vaccines. Virus dose and serologic response.
    Landrigan PJ; Murphy KB; Meyer HM; Parkman PD; Eddins DL; Witte JJ
    Am J Dis Child; 1973 Jan; 125(1):65-7. PubMed ID: 4683961
    [No Abstract]   [Full Text] [Related]  

  • 53. A field with a liver measles-mumps-rubella vaccine.
    Walters VW; Miller SA; Jackson JE; Kenny MT
    Clin Pediatr (Phila); 1975 Oct; 14(10):928-33. PubMed ID: 1100294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on measles in Thailand. II. Field trials of measles vaccine, with special reference to the K-L method.
    Tsuchinda P; Jayavasu J; Sangkawibha N; Okuno Y; Ueda S
    Biken J; 1967 Sep; 10(3):135-41. PubMed ID: 6081222
    [No Abstract]   [Full Text] [Related]  

  • 55. [The national vaccination program against measles].
    Cohen H; Brouwer R; Bijkerk H; Phaff JM
    Ned Tijdschr Geneeskd; 1978 Jan; 122(2):46-51. PubMed ID: 619292
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of Vitamin A supplementation on the immune response to measles vaccination.
    Cherian T; Varkki S; Raghupathy P; Ratnam S; Chandra RK
    Vaccine; 2003 Jun; 21(19-20):2418-20. PubMed ID: 12744873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of Edmonston-B and Schwarz measles vaccine in Malian children.
    Jean-Joseph P; Sow S; Casey HL; Imperato PJ; Henderson RH; Noble J
    Lancet; 1969 Mar; 1(7596):665-7. PubMed ID: 4179897
    [No Abstract]   [Full Text] [Related]  

  • 58. CLINICAL TRIAL OF FURTHER ATTENUATED MEASLES VACCINE.
    BENSON PF; BUTLER NR
    Guys Hosp Rep; 1964; 113():349-53. PubMed ID: 14225140
    [No Abstract]   [Full Text] [Related]  

  • 59. Experiences in mass prevention of measles by vaccination.
    Perkins FT
    Trans R Soc Trop Med Hyg; 1975; 69(1):24-5. PubMed ID: 1145714
    [No Abstract]   [Full Text] [Related]  

  • 60. [Serologic indices of measles immunity in children exposed to measles].
    Tikhonova NT; Khrometskaia TM; Ignat'eva GV; Gerasimova AG; Livanova LV
    Vopr Virusol; 1974; 19(0):357-63. PubMed ID: 4837951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.